Michael Katzenstein

Michael Katzenstein is Leader of the Interim Management practice, specializing in in-court and out-of-court restructurings. Mr. Katzenstein has decades of M&A and cross-border restructuring experience and is called upon to advise in many of the largest and most complex situations.

Mr. Katzenstein has led engagements for public and private companies across industries, including traditional and new media, entertainment, telecom, software and hardware. He has also worked with clients in the aerospace and defense, technology, ad-tech, ed-tech, bio-tech and bio-synthesis and other subscriber-based businesses and investment funds and international fund liquidations.

Mr. Katzenstein is regularly called upon to lead and assist in implementing strategies for companies in financial or operating distress or transition. He has led capital raising and M&A efforts for dozens of companies, and his clients include large and upper-middle corporations, as well as many major financial institutions and hedge funds.

Mr. Katzenstein has served on many occasions as a consulting or testifying witness on industry and corporate governance issues and has significant testimony experience, including in his capacity as Chief Restructuring Officer (“CRO”) or financial advisor in restructuring proceedings. He began his career as a M&A and securities lawyer and was a partner at a New York law firm.

Relevant Experience:

• Served as CRO of Zohar Funds, a Cayman-based investment fund; Global Cloud Xchange, a global data communications service provider; and Digital Domain, a special effects and media company
• Served as Chapter 11 financial advisor to OneWeb, a global satellite operator; Internap, a data services provider; National CineMedia, a movie advertising network; and Fusion Telecom, a telecom services company
• Served as Chapter 11 and Companies’ Creditors Arrangement Act (“CCAA”) financial advisor to Nortel’s $4 billion cross-border bondholders
• Served as financial advisor to the Official Committee of Creditors for Amyris, a bio-synthesis company; M*Modal, a medical transcription business; and Nextel International, an international telecommunications company
• Served as Chapter 11 advisor to Synergy Pharmaceuticals, a specialty drug company; and Audacy, a radio and streaming conglomerate